Fiinu PLC
30 July 2026
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ('MAR'), which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, until the release of this announcement]
30 July 2026
Fiinu plc
("Fiinu", the "Company" or the "Group")
Receipt of Requisition Notice
Fiinu plc (AIM: BANK) announces that it has received a requisition notice from Granicus Holdings OÜ ("Granicus"), which represents approximately 10.7% of the Company's issued share capital, requesting that the Board convenes a general meeting pursuant to section 303 of the Companies Act 2006. The Company confirms receipt of the correspondence and is currently reviewing its legal validity.
Shareholders are advised to take no action at this time.
The requisition proposes:
· an ordinary resolution to remove Dr. Marko Petteri Sjoblom as a director of the Company; and
· an advisory resolution to express the view that independent directors should review the Company's executive leadership and governance arrangements.
The Board notes that the requisition was received four days after the Company's Annual General Meeting ("AGM"), at which shareholders had the opportunity to consider the composition of the entire Board, all of whom are subject to annual reappointment in accordance with best corporate governance practice. All the directors were duly re-elected at the AGM. Granicus voted in favour of re-election of all of the Company's independent non-executive directors.
The Board maintains its complete confidence in Dr. Marko Sjoblom as its Chief Executive Officer, noting his position as the Company's founder, a long-term investor in, and provider of, financial support to the Company (including subscribing £1 million of new equity in July 2022 at a price of 20 pence per share), and the Company's largest shareholder with a 31.42% holding.
Granicus is wholly-owned by Mr. Karol Oleksa and members of the Oleksa family. As previously announced, the Company has commenced substantial contractual arbitration proceedings against the Mr. Oleksa and his wife, in respect of alleged breaches of post-completion restrictive covenants and non-compete obligations contained in the Share Purchase Agreement relating to the acquisition of Everfex P.S.A. in August 2025. Additionally, the Company has notified Granicus of substantial contractual claims arising from alleged breaches of seller warranties, representations and other obligations under the Share Purchase Agreement. The current, combined, value of the claims for damages in respect of these claims are in excess of £16 million, and may increase.
The Company has consistently stated that it intends to pursue these claims vigorously while remaining open to an appropriate commercial resolution where this would be in the best interests of all shareholders.
The Board believes shareholders will wish to consider whether Granicus's request to remove the Company's Chief Executive Officer, who is leading the Company's commercial strategy and representing the Company's shareholders interests in these ongoing proceedings would be in the best interests of the Company and its shareholders. The Board considers that Granicus' decision to submit the requisition is disruptive, following last week's shareholder approvals at the AGM, and is intended to distract the Board's attention from the proper prosecution of its claims against Granicus, Mr. Oleksa and associated parties.
The Board however recognises the statutory rights of shareholders to requisition a general meeting under the Companies Act 2006 and will act in accordance with its legal obligations.
If, following completion of the Company's legal review, the requisition is determined to be valid, the Company will comply with its obligations under the Companies Act 2006 to call a general meeting to consider the proposed resolutions and, in due course, will provide shareholders with the Board's formal voting recommendation.
Further announcements will be made as appropriate.
The Directors of the Company accept responsibility for the content of this announcement.
|
Fiinu Plc David Hopton (Chair) / Dr. Marko Sjoblom - CEO |
Tel: +44 (0) 1932 629 532 |
|
SPARK Advisory Partners Limited (Nomad) Mark Brady / Angus Campbell |
Tel: +44 (0) 203 368 3550/3551 |
|
Marex Financial (Joint Broker) Angelo Sofocleous / Keith Swann / Matt Bailey |
Tel: +44 (0) 207 655 6000 Email: corporate@marex.com |
|
Oberon Investment Limited (Joint Broker) Nick Lovering / Adam Pollock / Mike Seabrook |
Tel: +44 (0)203 179 5300 |
|
|
|
|
Brazil (Financial PR) Joshua van Raalte / Christine Webb |
Tel: +44 (0) 207 785 7383 |
About Fiinu
Fiinu Plc ("Fiinu"), founded in 2017, is a publicly traded (LSE: BANK) fintech Group, admitted to trading on the AIM Market of the London Stock Exchange, that has developed the world's first Bank Independent Overdraft® platform. The platform, offered as a white labelled solution to banks, allows lenders to offer Fiinu's flagship product, Plugin Overdraft® to retail consumers. Plugin Overdraft® is an unbundled overdraft solution that allows customers to have an overdraft without changing their existing bank.
For more information, please visit www.fiinuplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.